The action of aldosterone to increase the renal excretion of potassium and reduce urinary losses of sodium has been known for nearly 30 years. Our understanding of the mechanism of action of aldosterone, however, has been derived primarily from in vitro studies on anuran and mammalian tissues. The interpretation of experiments performed in vivo has often been unclear because of technical problems related to maintaining plasma levels of endogenous adrenal hormones at basal or high physiological levels and uncertainties related to biological equivalent doses in studies where synthetic glucocorticoids have been used to substitute for cortisol or corticosterone. To evaluate the in vivo action of aldosterone and glucocorticoids on epithelial tissues, an experimental animal model was developed in which chronic physiological levels of both types of adrenal hormones could be altered by experimental design.
0 1983 by the International Society of Nephrology (3) Sodium deficiency. These animals were fed a sodium-free paste diet for 5 to 8 days and had free access to tap water.
Adrenalectomized animals with hormone replacement. Animals were lightly anesthesized with pentobarbitol, and bilateral adrenalectomy was performed by flank incisions. Hormone replacement with aldosterone and corticosterone was achieved in the following manner.
Chronic infusion of aldosterone was performed with osmotic minipumps (model 2001 or 2002, Alza Corporation, Palo Alto, California) implanted in a subcutaneous tunnel in the interscapular area. Aldosterone was dissolved in an ethanol-0.15 M NaCl solution, in which final ethanol concentration did not exceed 5%. To insure constant rates of infusion at the time of implantation, the pumps were incubated in 0.15 M NaCl at 37' C for 4 hr before use. In vitro studies, using 3~ methoxy-inulin, demonstrated that infusion rates were approximately 1 pVhr for at least 1 week, as reported by the manufacturer.
Since corticosterone is poorly soluble in saline and organic solvents, replacement dosages could not be administered by the minipump technique. Therefore, the hormone was implanted as pellets in the interscapular area. The method of pellet formation has been previously described [ 2 ] . Briefly, corticosterone (Sigma Chemical Corp., St. Louis, Missouri) was weighted, carefully melted on a stainless steel spoon over a low gas flame, and poured into individual 5 x 5 mm holes drilled into a paraffin block. In studies in which less than 60 mg of corticosterone per pellet were used, cholesterol was added to the corticosterone to provide a final weight of 60 mg per pellet. Adrenalectomized animals not given the replacement of aldosterone were given 0.15 M NaCl with 5% glucose as a drinking solution. In one group of animals dexamethasone was administered subcutaneously in a dose of 5 pg1100 body weight at 12-hr intervals.
Determination of transmural potential difference in rat colon.
To determine the physiologic action of adrenal hormones on epithelia responsive to the action of aldosterone, the transmural potential difference (PD) was measured in the distal colon by methods previously described [3] . Since previous studies have shown that the PD varies along the course of the colon, measurements were made at 0.5-cm intervals from the anus to a site 6 cm proximal to the anus.
Methods used to determine plasma aldosterone, corticosterone, and dexamethasone levels. Plasma corticosterone levels were determined by the competitive protein binding method described by Murphy [4] . Briefly, two ethanol extractions of rat plasma (0.1 ml plasma: 1.0 ml ethanol) were combined, dried under nitrogen, and allowed to compete with tritiated cortico-sterone (New England Nuclear Corp., Boston, Massachusetts) for binding sites on human CBG at 4°C. After equilibration CBG-bound corticosterone was separated from the unbound fraction by the addition of dextran-coated charcoal, followed by centrifugation. The supernatant was decanted into scintillation fluid and the activity of 3H-corticosterone was determined in a scintillation counter (Packard Tri-Carb, Packard Instruments, Downers Grove, Illinois). The concentration of corticosterone was calculated by comparing the percent of corticosterone bound to unknowns with standards processed in the same way.
Measurement of plasma aldosterone was accomplished by combining the chromatographic purification method of Buhler et al [5] with a commercial aldosterone radioimmunoassay kit (Diagnostic Products, Kald-2, Los Angeles, California). Purification of the samples prior to radioimmunoassay was necessary due to the relatively high crossreactivity of the commercial aldosterone antiserum with corticosterone (manufacturer's information) and possibly with other substances occurring naturally in rat plasma.
Direct radioimmunoassay of aldosterone in nonpurified plasma samples from unstressed rats yielded values that were several fold higher (35 ng/dl) than previously reported values of 5 to 10 ngldl for samples collected under comparable circumstances [6] [7] [8] . Similarly, samples from adrenalectomized rats treated only with corticosterone replacement had apparent aldosterone concentrations of 5.2 ng/dl that were inconsistent with adrenalectomy. After the addition of the purification step to the aldosterone assay, plasma samples both from unstressed rats and adrenalectomized animals with corticosterone substitution alone yielded values consistent with previously reported values, and averaged 4.60 0.7 ngldl and "undetectable,"
respectively. Briefly, purification of the samples consisted of the following: Methylene chloride extraction was performed in rat plasma and plasma-based aldosterone standards (7.0 ml CH2CI2: 1.0 ml sample). Five milliliters of the organic phase were evaporated 1 hr under nitrogen to dryness, reconstituted in small volumes (0,1 ml) of ethyl acetate and iso-octane (0.4 ml), and the entire 0.5-mi volume was applied to small, disposable columns of diatomaceous silica for chromatography. Subsequently, each tube was rinsed with 0.05 ml ethyl acetate and 0.2 ml of isooctane. The entire volume of this rinse was applied to the column. The entire plasma volume equivalent applied to the column was 714 d. The columns were made from disposable 5-ml glass pipettes (Kimble #72120-5110) which were shortened by 7 cm, fire-polished, and plugged at the narrow end with a glass bead. The packing material (approximately 1 glcolumn) was acid-washed diatomaceous silica (Sigma Chemical Co., #D5384), thoroughly mixed with 40% ethylene glycol in water, in a 3:1 (w/w) ratio.
Three successive washes (volume, 3.5 ml each) of increasing concentrations of ethyl acetate in iso-octane were applied to the columns. The first two washes (15 and 40% ethyl acetate) were discarded. Aldosterone was eluted from the column with the final wash of 60% ethyl acetate, All elutions were assisted by the application of approximately 1.5 pounds pressure of nitrogen through a tubing-and-rubber-stopper manifold. The aldosterone-containing elutions were evaporated to dryness under nitrogen and reconstituted in 1.5 ml borate-saline buffer, pH 8.4. Radioimmunoassay was carried out according to the manufacturer's protocol and involved a '251-labeled aldosterone, single antibody method, using dextran-coated charcoal to separate antibody-bound from free hormone at 4°C. The antibodybound moiety was counted in a gamma counter (Searle Analytic, Model 1195). Standard curve results were plotted on log-log paper, and the concentration of unknowns were estimated from the standard curve.
The concentration of dexamethasone in rat plasma was Values are presented as the mean SEM. Comparison between means was performed using Student's t test.
Results. Endogenous plasma levels of aldosterone and corticosterone. To replace adrenalectomized animals with physiologic levels of adrenal hormones, it was necessary to estimate endogenous plasma levels in rats with intact adrenal glands under various physiologic conditions. Plasma levels of aldosterone in control rats, animals on a high potassium diet, and sodium deficient rats were measured under basal and unstressed conditions and are shown in the upper panel of Figure  1 . In control animals the basal level was 4.6 0.7 ng/dl, which agreed with previous reports [6-81, and rose to 62 7 ng/dl after the stress of surgery and anesthesia. Levels in animals on a high potassium diet were 35 7 and 125 25 ng/dl, respectively, under the same conditions. In sodium-deprived rats the basal level of aldosterone was elevated markedly to 473 66 ngldl, as previously reported [8] .
Plasma corticosterone levels are shown in the lower panel of Figure 1 . The basal level of 9.0 1.8 g/dl in control animals was increased to 30.0 1.2 by acute stress. Basal and stressed values in animals on a high potassium diet were comparable to levels in control animals under the same conditions. In sodiumdeprived rats the basal corticosterone level was 15 2.2 g/di.
Previous studies in unstressed animals fed without restriction demonstrated a normal circadian rhythm of plasma corticosterone in the rat, ranging from low values of approximately 2 g/dl at approximately 9 A.M. to peak values of about 21 g/dl at 7 P.M. [9] . A recent report indicates that free corticosterone, which is about 20% of total serum corticosterone, exhibits the same diurnal variation [10] .
Adrenalectomizedanimals with hormone replacement. Studies were performed to correlate the rate of delivery of aldosterone and the replacement of corticosterone with plasma levels of aldosterone and corticosterone. Aldosterone was chronically infused, via osmotic minipumps at variable rates for 5 days into adrenalectomized animals not treated with corticosterone. Figure 2 demonstrates mean plasma values in five pairs of animals in which each pair was infused at different delivery rates ranging from 1.25 g/10O g body weight per day to 20 tg/l00 g body weight per day and shows a nearly linear relationship over the dose range used. At the lowest level of 1.25 g/l00 g body weight per day, the plasma level was 8.5 ngldl, and at 0.8 g/l00 g body weight per day, not shown in the figure, the level was 4.1 0.2 ngldl in 18 animals. Since the plasma level in unstressed control animals was approximately 5 ngldl, these results indicate for the first time that the basal endogenous production rate of aldosterone is approximately 1.0 g/100 g body weight per day. Previous studies on the endogenous production rate of aldosterone have been performed in the stressed rat and demonstrated a rate of 3.0 to 3.5 g/100 g body weight [II, 12] .
Meyer et al [2] reported that implantation of corticosterone pellets resulted in stable plasma levels of the hormone for about 15 days, although transiently higher levels were recorded 2 to 3 days after surgery, Serial measurements of plasma corticosterone in five animals for 7 days after implantation of two pellets of 60 mg of corticosterone demonstrated a similar profile with stable plasma levels between 3 and 7 days. The plasma level of corticosterone 6 to 7 days after adrenalectomy and implantation of two pellets of 60 mg of corticosterone was 9.8 0.5 .tg/dl in 12 animals: This value was not statistically different from basal midmorning levels in control animals with intact adrenal glands.
Since previous workers have used dexamethasone for glucocorticoid replacement in adrenalectomized animals, usually administered in a dose of approximately 5 ig/100 g body weight per 12 hr in the rat by bolus subcutaneous injection [3, 13] . Experiments were performed with that regimen to determine plasma levels of dexamethasone in three animals for approximately 3 hr after injection. Plasma levels of dexamethasone rapidly increased after injection to an average level of 3.1 0.2 g/dl at 60 mm, after which plasma levels slowly rose to 3.8 0.3 g/dl 180 mm after injection. Physiological replacement of aldosterone and corlicosterone in adrenalectomized animals. The goal in these experiments was to establish a hormone-replaced adrenalectomized animal comparable to control animals in the basal unstressed state.
Two different criteria were used to determine the dose levels of aldosterone and corticosterone.
The first method used basal plasma levels in unstressed animals as a guide for replacement. Basal plasma levels of aldosterone were achieved by a chronic infusion rate of 0.8 g/l00 g body weight per day, providing a stable plasma level of 4.1 0.2 ng/dl for up to 7 days, as noted above. The basal level of corticosterone, of approximately 10 Lg/dl, was achieved by the subcutaneous implantation of two pellets of 60 mg corticosterone resulting in a mean plasma level of 9.8 0.5 tg/dl between 5 and 7 days after surgery. Since previous studies suggest that the biological effects of transient high plasma levels of glucocorticoids may persist for at least 48 hr [14] , all physiologic experiments were performed at least 5 days after replacement therapy was initiated because of the higher plasma corticosterone levels within the first few days of pellet implantation.
The second method used a physiological parameter because it was assumed that basal hormonal replacement therapy should result in electrical properties in target epithelia comparable to those found in control animals with intact adrenal glands. Since aldosterone responsive epithelia in the distal nephron is relatively inaccessible to direct analysis, the potential difference across the large intestine was used as an index of mineralocorticoid action. Figure 3 demonstrates that the profile of potential difference along the colon of control animals and the mean value of 26.6 6.6 mV (lumen negative) at 2.5 cm from the anus agreed with previous reports [15] . Following adrenalectomy the potential difference was reduced approximately 50% between 2 and 4 cm of the distal colon. The effect of aldosterone on colonic potential difference in ten adrenalectomized animals infused with aldosterone at varying delivery rates is shown in Figure 4 . To avoid the possible action of corticosterone to stimulate potential difference, glucocorticoids were not administered to these animals. Inspection of Figure 4 shows that a normal potential difference of 20 to 30 mV was associated with plasma aldosterone levels of 5 to 10 ng/dl; at plasma levels greater than 25 ngldl a marked increase in potential difference was observed. These animals gained an average 5.3 g/day in body weight.
Additional dose response studies were performed in five pairs of animals, in which each pair was implanted with a different amount of corticosterone, in addition to receiving the physiologic replacement dose of aldosterone of 0.8 g/100 g body weight per day. Results, not shown, indicated that a plasma level of corticosterone greater than 5 g/dl was associated with an increase in colonic potential difference above control. Table 1 lists the colonic potential difference in unstressed control animals and adrenalectomized rats with basal levels of aldosterone and various plasma levels of corticosterone or dexamethasone. It is apparent that the colonic potential difference in substituted animals was comparable to control animals only when the sustained level of corticosterone was less than 8 g/dl. In substituted animals with higher plasma levels of corticosterone the colonic potential difference was increased to 70 to 80 mV. Inspection of Table 1 also demonstrates that administration of dexamethasone in a dose of 5 g/l00 g body weight/12 hr was associated with a marked increase in colonic potential difference. In addition to the changes in the electrical properties of large intestine, loss in body weight was induced by the administration of dexamethasone and sustained plasma levels of corticosterone greater than or equal to 8 g/dl, compared to unstressed control and adrenalectomized animals with lower plasma levels of corticosterone. These data suggest therefore, that sustained plasma levels of corticosterone of less than 8 g/dl provide physiological replacement, while higher levels alter basal epithelial function and increase tissue catabolism.
Discussion
This study demonstrates a method for adrenal hormone replacement in the rat in which stable plasma levels of aldosterone and corticosterone can be maintained for at least 7 days.
Moreover, results of this study indicate that basal physiological replacement of aldosterone in adrenalectomized animals requires an infusion rate of approximately 1 g/l00 g body weight per day and plasma levels of 4 to 5 ng/dl; this plasma level compares favorably with the value in unstressed animals with intact adrenal glands. Determination of the physiological level of corticosterone replacement was complicated by an inability to simulate the normal diurnal variation in plasma levels found in the rat and other mammals. Nevertheless, in regard to the electrical properties of an epithelium responsive to aldosterone, physiological replacement was achieved with sustained plasma levels less than 8 g/dl, since higher sustained plasma levels were associated with an increase in the potential difference of large intestine and signs of increased catabolism reflected by The number in parenthesis indicates the number of animals studied. The transmural potential difference was measured 2.5 cm from the anus. b The value is statistically different from control at P < 0.05.
hormones is necessary for in vitro experiments designed to examine the action of chronic physiologic elevations of plasma aldosterone or glucocorticoid hormones. The interpretation of previous experiments in which those agents have been administered to animals has been unclear for several reasons. First, the effect of hormonal substances administered to experimental animals with intact adrenal glands may be obscured by increased endogenous production of aldosterone and either corticosterone or cortisone due to stress [11, 16] . Second, the action of adrenal hormones may be modified in adrenalectomized animals treated only with saline solutions because of changes in intracellular ion concentration [17] . Third, organ perfusion is markedly reduced in adrenalectomized animals not replaced with glucocorticoid hormones [18] , and conversely, renal blood flow and GFR increase above control by the administration of pharmacological doses of glucocorticoid agents [19, 20] .
The results of this study also demonstrate that the administration of synthetic glucocorticoids by intermittent injection, in a manner designed to provide an amount equivalent to the estimated daily production of the endogenous hormone, may result in high plasma levels of the synthetic agent. The subcutaneous injection of 5 g/100 g body weight of dexamethasone was associated with a plasma level of approximately 4 jg/dl for at least 3 hr. This value was similar to the estimated physiological replacement level of corticosterone. Since dexamethasone is largely available to receptor sites because of its low affinity binding to albumin [21] , in contrast to corticosterone of which about 80% of the amount in plasma is tightly bound to transcortin [22, 23] , the observed plasma levels were in a pharmacological range and caused hyperpolarization of the transmural potential different in colon and loss in body weight.
Synthetic glucocorticoids could be administered in this animal model with the osmotic minipump for glucocorticoid replacement. Although not primarily related to the results of this study, it should be noted that the physiological replacement dose of synthetic hormones cannot be calculated with confidence from published reports on relative potencies, since those data are mainly derived from comparisons on anti-inflammatory, lymphopenic, and glycolytic effects [24] . Studies related to relative mineralocorticoid action of glucocorticoid hormones involved measurements of electrolyte excretion after in vivo administration, and changes in GFR and relative binding to plasma proteins were not considered [19] . In the present study we elected to use the endogenous glucocorticoid in the rat since most biological studies are usually concerned with the action of adrenal derivatives within the physiological range.
In summary, an experimental animal model is described which permits an evaluation of the chronic action of aldosterone and corticosterone on epithelial function under conditions where the plasma levels of each type of major adrenal hormone can be regulated by experimental design. Experiments with this model have demonstrated the basal physiological replacement level of plasma aldosterone and the plasma level of corticosterone which does not influence the electrical properties of an aldosterone responsive epithelium.
